Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

Alteration of gene expression profiles during mycoplasma-induced malignant cell transformation

Authors: Shimin Zhang, Shien Tsai, Shyh-Ching Lo

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

Mycoplasmas are the smallest microorganisms capable of self-replication. Our previous studies show that some mycoplasmas are able to induce malignant transformation of host mammalian cells. This malignant transformation is a multistage process with the early infection, reversible and irreversible stages, and similar to human tumor development in nature. The purpose of this study is to explore mechanisms for this malignant transformation.

Methods

To better understand mechanisms for this unique process, we examined gene expression profiles of C3H cells at different stages of the mycoplasma-induced transformation using cDNA microarray technology. A total of 1185 genes involved in oncogenesis, apoptosis, cell growth, cell-cycle regulation, DNA repair, etc. were examined. Differences in the expression of these genes were compared and analyzed using the computer software AtlasImage.

Results

Among 1185 genes screened, 135 had aberrant expression at the early infection stage, 252 at the reversible stage and 184 at the irreversible stage. At the early infection stage, genes with increased expression (92 genes) were twice more than those with decreased expression (42 genes). The global gene expression at the reversible stage appeared to be more volatile than that at any other stages but still resembled the profile at the early infection stage. The expression profile at the irreversible stage shows a unique pattern of a wide range of expression levels and an increased number of expressing genes, especially the cancer-related genes. Oncogenes and tumor suppressors are a group of molecules that showed significant changes in expression during the transformation. The majority of these changes occurred in the reversible and irreversible stages. A prolonged infection by mycoplasmas lead to the expression of more cancer related genes at the irreversible stage.

Conclusion

The results indicate that the expression profiles correspond with the phenotypic features of the cells in the mycoplasma induced transformation process. The early mycoplasma infection stage shares a common phenomenon with many other acute infections, genes with increased expression significantly outnumbering those with decreased expression. The reversible stage is a transition stage between benignancy and malignancy at the molecular level. Aberrant expression of oncogenes and tumor repressors plays a key role in mycoplasma-induced malignant transformation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maniloff J, McElhaney RN, Finch LR, Baseman JB: Mycoplasmas: Molecular Biology and Pathogenesis. 1992, Washington, DC: American Society of Microbiology Maniloff J, McElhaney RN, Finch LR, Baseman JB: Mycoplasmas: Molecular Biology and Pathogenesis. 1992, Washington, DC: American Society of Microbiology
2.
go back to reference Feng SH, Tsai S, Rodriguez J, Lo SC: Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol. 1999, 19 (12): 7995-8002.CrossRefPubMedPubMedCentral Feng SH, Tsai S, Rodriguez J, Lo SC: Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol. 1999, 19 (12): 7995-8002.CrossRefPubMedPubMedCentral
3.
go back to reference Tsai S, Wear DJ, Shih JW, Lo SC: Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA. 1995, 92 (22): 10197-10201. 10.1073/pnas.92.22.10197.CrossRefPubMedPubMedCentral Tsai S, Wear DJ, Shih JW, Lo SC: Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA. 1995, 92 (22): 10197-10201. 10.1073/pnas.92.22.10197.CrossRefPubMedPubMedCentral
4.
go back to reference Zhang S, Wear DJ, Lo S: Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol. 2000, 27 (1): 43-50. 10.1111/j.1574-695X.2000.tb01410.x.CrossRefPubMed Zhang S, Wear DJ, Lo S: Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol. 2000, 27 (1): 43-50. 10.1111/j.1574-695X.2000.tb01410.x.CrossRefPubMed
5.
go back to reference Reznikoff CA, Brankow DW, Heidelberger C: Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 1973, 33 (12): 3231-3238.PubMed Reznikoff CA, Brankow DW, Heidelberger C: Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 1973, 33 (12): 3231-3238.PubMed
6.
go back to reference Lo S-C: Mycoplasmas and AIDS. Mycoplasmas, Molecular biology and pathogenesis. Edited by: Maniloff J, McElhaney RN, Flinch LR, Baseman JB. 1992, Washington DC: American Society for Microbiology Lo S-C: Mycoplasmas and AIDS. Mycoplasmas, Molecular biology and pathogenesis. Edited by: Maniloff J, McElhaney RN, Flinch LR, Baseman JB. 1992, Washington DC: American Society for Microbiology
7.
go back to reference Macpherson I, Russell W: Transformations in hamster cells mediated by mycoplasmas. Nature. 1966, 210 (43): 1343-1345. 10.1038/2101343a0.CrossRefPubMed Macpherson I, Russell W: Transformations in hamster cells mediated by mycoplasmas. Nature. 1966, 210 (43): 1343-1345. 10.1038/2101343a0.CrossRefPubMed
8.
go back to reference Kotani H, Phillips D, McGarrity GJ: Malignant transformation of NIH-3T3 and CV-1 cells by a helical mycoplasma, Spiroplasma mirum, strain SMCA. In Vitro Cell Dev Biol. 1986, 22 (12): 756-762.CrossRefPubMed Kotani H, Phillips D, McGarrity GJ: Malignant transformation of NIH-3T3 and CV-1 cells by a helical mycoplasma, Spiroplasma mirum, strain SMCA. In Vitro Cell Dev Biol. 1986, 22 (12): 756-762.CrossRefPubMed
9.
go back to reference Laneuville P, Timm M, Hudson AT: bcr/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors. Cancer Res. 1994, 54 (5): 1360-1366.PubMed Laneuville P, Timm M, Hudson AT: bcr/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors. Cancer Res. 1994, 54 (5): 1360-1366.PubMed
10.
go back to reference Zhang S, Tsai S, Geissel A, Becker R, Lo S-C: Mycoplasma-mediated malignant transformation of IL-3 dependent 32D hematopoietic cells is associated with constitutive expression of a high level of c-Myc gene. 99th General Meeting of the the American Society for Microbiology. 1999, Atlantic City, 324- Zhang S, Tsai S, Geissel A, Becker R, Lo S-C: Mycoplasma-mediated malignant transformation of IL-3 dependent 32D hematopoietic cells is associated with constitutive expression of a high level of c-Myc gene. 99th General Meeting of the the American Society for Microbiology. 1999, Atlantic City, 324-
11.
go back to reference Zhang S, Tsai S, Wu TT, Li B, Shih JW, Lo SC: Mycoplasma fermentans infection promotes immortalization of human peripheral blood mononuclear cells in culture. Blood. 2004, 104 (13): 4252-4259. 10.1182/blood-2004-04-1245.CrossRefPubMed Zhang S, Tsai S, Wu TT, Li B, Shih JW, Lo SC: Mycoplasma fermentans infection promotes immortalization of human peripheral blood mononuclear cells in culture. Blood. 2004, 104 (13): 4252-4259. 10.1182/blood-2004-04-1245.CrossRefPubMed
12.
go back to reference Zhang B, Shih JW, Wear DJ, Tsai S, Lo SC: High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation. Proc Soc Exp Biol Med. 1997, 214 (4): 359-366.CrossRefPubMed Zhang B, Shih JW, Wear DJ, Tsai S, Lo SC: High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation. Proc Soc Exp Biol Med. 1997, 214 (4): 359-366.CrossRefPubMed
13.
go back to reference Zhang B, Tsai S, Shih JW, Wear DJ, Lo SC: Absence of mycoplasmal gene in malignant mammalian cells transformed by chronic persistent infection of mycoplasmas. Proc Soc Exp Biol Med. 1998, 218 (1): 83-89.CrossRefPubMed Zhang B, Tsai S, Shih JW, Wear DJ, Lo SC: Absence of mycoplasmal gene in malignant mammalian cells transformed by chronic persistent infection of mycoplasmas. Proc Soc Exp Biol Med. 1998, 218 (1): 83-89.CrossRefPubMed
14.
go back to reference Leung YF, Cavalieri D, Cui X, Churchill GA, Yang YH, Speed T, Schofield D, Triche TJ, Buckley MJ, Speed TP, Schofield D, Triche TJ, Buckley MJ, Speed TP, Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N, Quackenbush J: Fundamentals of cDNA microarray data analysis. Trends Genet. 2003, 19 (11): 649-659. 10.1016/j.tig.2003.09.015.CrossRefPubMed Leung YF, Cavalieri D, Cui X, Churchill GA, Yang YH, Speed T, Schofield D, Triche TJ, Buckley MJ, Speed TP, Schofield D, Triche TJ, Buckley MJ, Speed TP, Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, Hughes JE, Snesrud E, Lee N, Quackenbush J: Fundamentals of cDNA microarray data analysis. Trends Genet. 2003, 19 (11): 649-659. 10.1016/j.tig.2003.09.015.CrossRefPubMed
15.
go back to reference Reimers M: Statistical analysis of microarray data. Addict Biol. 2005, 10 (1): 23-35. 10.1080/13556210412331327795.CrossRefPubMed Reimers M: Statistical analysis of microarray data. Addict Biol. 2005, 10 (1): 23-35. 10.1080/13556210412331327795.CrossRefPubMed
16.
go back to reference Aujame L, Burdin N, Vicari M: How microarrays can improve our understanding of immune responses and vaccine development. Ann N Y Acad Sci. 2002, 975: 1-23.CrossRefPubMed Aujame L, Burdin N, Vicari M: How microarrays can improve our understanding of immune responses and vaccine development. Ann N Y Acad Sci. 2002, 975: 1-23.CrossRefPubMed
17.
go back to reference Vernet G: DNA-chip technology and infectious diseases. Virus Res. 2002, 82 (1–2): 65-71.PubMed Vernet G: DNA-chip technology and infectious diseases. Virus Res. 2002, 82 (1–2): 65-71.PubMed
18.
go back to reference Vertegaal AC, Kuiperij HB, van Laar T, Scharnhorst V, van der Eb AJ, Zantema A: cDNA micro array identification of a gene differentially expressed in adenovirus type 5-versus type 12-transformed cells. FEBS Lett. 2000, 487 (2): 151-155. 10.1016/S0014-5793(00)02339-5.CrossRefPubMed Vertegaal AC, Kuiperij HB, van Laar T, Scharnhorst V, van der Eb AJ, Zantema A: cDNA micro array identification of a gene differentially expressed in adenovirus type 5-versus type 12-transformed cells. FEBS Lett. 2000, 487 (2): 151-155. 10.1016/S0014-5793(00)02339-5.CrossRefPubMed
19.
go back to reference Statnikov A, Aliferis CF, Tsamardinos I, Hardin D, Levy S: A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics. 2005, 21 (5): 631-643. 10.1093/bioinformatics/bti033.CrossRefPubMed Statnikov A, Aliferis CF, Tsamardinos I, Hardin D, Levy S: A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics. 2005, 21 (5): 631-643. 10.1093/bioinformatics/bti033.CrossRefPubMed
20.
go back to reference Simms D, Cizdziel PE, Chomczynski P: TRIzol: A new reagent for optimal single-step isolation of RNA. Focus. 1993, 15: 532-535. Simms D, Cizdziel PE, Chomczynski P: TRIzol: A new reagent for optimal single-step isolation of RNA. Focus. 1993, 15: 532-535.
21.
go back to reference Tully JG: The Emmy Klieneberger-Nobel Award lecture. Reflections on recovery of some fastidious mollicutes with implications of the changing host patterns of these organisms. Yale J Biol Med. 1983, 56 (5–6): 799-813.PubMedPubMedCentral Tully JG: The Emmy Klieneberger-Nobel Award lecture. Reflections on recovery of some fastidious mollicutes with implications of the changing host patterns of these organisms. Yale J Biol Med. 1983, 56 (5–6): 799-813.PubMedPubMedCentral
22.
go back to reference Rosenberger CM, Pollard AJ, Finlay BB: Gene array technology to determine host responses to Salmonella. Microbes Infect. 2001, 3 (14–15): 1353-1360. 10.1016/S1286-4579(01)01497-6.CrossRefPubMed Rosenberger CM, Pollard AJ, Finlay BB: Gene array technology to determine host responses to Salmonella. Microbes Infect. 2001, 3 (14–15): 1353-1360. 10.1016/S1286-4579(01)01497-6.CrossRefPubMed
23.
go back to reference Kato-Maeda M, Gao Q, Small PM: Microarray analysis of pathogens and their interaction with hosts. Cell Microbiol. 2001, 3 (11): 713-719. 10.1046/j.1462-5822.2001.00152.x.CrossRefPubMed Kato-Maeda M, Gao Q, Small PM: Microarray analysis of pathogens and their interaction with hosts. Cell Microbiol. 2001, 3 (11): 713-719. 10.1046/j.1462-5822.2001.00152.x.CrossRefPubMed
24.
go back to reference Radhakrishnan S, Otte J, Enam S, Del Valle L, Khalili K, Gordon J: JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol. 2003, 77 (19): 10638-10644. 10.1128/JVI.77.19.10638-10644.2003.CrossRefPubMedPubMedCentral Radhakrishnan S, Otte J, Enam S, Del Valle L, Khalili K, Gordon J: JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol. 2003, 77 (19): 10638-10644. 10.1128/JVI.77.19.10638-10644.2003.CrossRefPubMedPubMedCentral
25.
go back to reference McCaffrey RL, Fawcett P, O'Riordan M, Lee KD, Havell EA, Brown PO, Portnoy DA: A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc Natl Acad Sci USA. 2004, 101 (31): 11386-11391. 10.1073/pnas.0403215101.CrossRefPubMedPubMedCentral McCaffrey RL, Fawcett P, O'Riordan M, Lee KD, Havell EA, Brown PO, Portnoy DA: A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc Natl Acad Sci USA. 2004, 101 (31): 11386-11391. 10.1073/pnas.0403215101.CrossRefPubMedPubMedCentral
26.
go back to reference Felsher DW: Reversibility of oncogene-induced cancer. Curr Opin Genet Dev. 2004, 14 (1): 37-42. 10.1016/j.gde.2003.12.008.CrossRefPubMed Felsher DW: Reversibility of oncogene-induced cancer. Curr Opin Genet Dev. 2004, 14 (1): 37-42. 10.1016/j.gde.2003.12.008.CrossRefPubMed
28.
go back to reference Marmor MD, Skaria KB, Yarden Y: Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys. 2004, 58 (3): 903-913. 10.1016/j.ijrobp.2003.06.002.CrossRefPubMed Marmor MD, Skaria KB, Yarden Y: Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys. 2004, 58 (3): 903-913. 10.1016/j.ijrobp.2003.06.002.CrossRefPubMed
29.
go back to reference Munger K: Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest. 2002, 20 (1): 71-81. 10.1081/CNV-120000369.CrossRefPubMed Munger K: Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest. 2002, 20 (1): 71-81. 10.1081/CNV-120000369.CrossRefPubMed
Metadata
Title
Alteration of gene expression profiles during mycoplasma-induced malignant cell transformation
Authors
Shimin Zhang
Shien Tsai
Shyh-Ching Lo
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-116

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine